Search

This researched work is on the effect of social media communication on select tourist sites in Nigeria.Social medial enables people to share the most significant memories from their travels with a vast audience. Social media is a computer-based technology that facilitates the sharing of ideas, thoughts, and information through the building of virtual network. Tourist site's are places people visit for it's inherent nature usually when they are on vacation. The Problem of study was identified by a researcher who posits that social media communication helps organizations to reach their customers and potential customers. The general objective investigated the effects of social media communications on select tourist site's in Nigeria.This study will be of immense benefit to Future researchers, Upcoming generation and Tourist site's across the world. This research equally was achieved through primary data, later analysed with SPSS statistical package. However, simple linear regression was employed and findings revealed that the correction coefficients are very high as against the p-value. This depict that social media communications( WhatsApp and Facebook) affects tourist site's highly in the selecedt tourist site's leading to the rejection of the two null hypotheses .Concluding that social media communications WhatsApp and Facebook are significant on tourist site's in Nigeria. The researcher recommends that tourist site's and indeed all other organizations who wishes to remain in the business should endeavor to communicate with their customers and potential customers through Facebook and WhatsApp More as More people are in the use of both communications now than before.

Background Outpatient parenteral antibiotic therapy (OPAT) is a therapeutic option for patients who require longer intravenous (IV) antimicrobial courses, yet do not need to remain hospitalized. HarrisHealth system OPAT programs implement a disposable elastomeric continuous infusion pump (eCIP) for IV antibiotics. Here we report the clinic-demographic features, outcomes of a cohort of patients receiving OPAT via eCIP (OPAT-eCIP), as well as the cost-effectiveness of OPAT in comparison to standard inpatient care. Methods We retrospectively obtained the clinic-demographic characteristics and outcomes of 91 patients discharged from HarrisHealth-affiliated hospitals from December 2018 to February 2021 who underwent OPAT-eCIP. We then compared the total costs associated with home OPAT-eCIP care with that of an equivalent of inpatient IV antimicrobial treatment based on previous studies. Results We identified 481 total OPAT patients; 91 (18.9%) received intravenous antibiotics via eCIP, with two initiating therapy outpatient. In total, 1925 days of IV antimicrobial therapy were administered outpatient by OPAT-eCIP, with a median treatment course of 12 days. Eighty-three (92.2%) patients completed their antimicrobial course, with 85 (93.4%) cured of respective infections (Table 1). Antimicrobial-associated adverse events and PICC line associated complications were 6.6% and 14.3% respectively. 30-day hospital readmission rates were under 10% with 21 patients (23.1%, 28 total visits) presenting to the emergency room over the course of IV therapy. Estimated costs of OPAT-eCIP care over the study period ranged from &417,000-&576,750 with costs of equivalent inpatient care estimated at &2,945,250 to &3,927,000; estimated overall cost savings of OPAT-eCIP were &2,368,500 to &3,509,900 (Table 2). Table 1. Characteristics and Outcomes of Patients Receiving Continuous IV Antibiotics via Disposable Elastomeric Pump Table 2. Cost Analysis Comparison of OPAT-eCIP therapy versus inpatient antimicrobial therapy in patients from December 2018 from February 2021 Conclusion OPAT-eCIP therapy in a cohort of patients was highly effective and well-tolerated. While ED visit frequency indicates the necessity of close patient monitoring, low 30-day hospital readmission rates were encouraging. Along with the above, the significant cost savings demonstrated when compared with standard inpatient antimicrobial therapy suggest that OPAT-eCIP should be increasingly utilized as an effective therapeutic option. Disclosures All Authors: No reported disclosures